Losing excess weight improves several things that drive heart disease: blood pressure, triglycerides, blood sugar and, to a smaller degree, LDL cholesterol. That part is well proven.
Whether weight loss by itself leads to fewer heart attacks and strokes is a harder question, and the honest answer is mixed. The largest lifestyle trial did not show it. A newer medicine trial did, but only in people who already had heart disease.
Key takeaways
- Trials consistently show that losing weight brings down blood pressure, triglycerides and blood sugar.
- LDL cholesterol falls only a little with weight loss, so it needs its own check.
- The Look AHEAD trial found no drop in heart attacks and strokes from an intensive diet and activity program in adults with type 2 diabetes.
- One large trial of a weight-loss medicine did reduce events, in adults who already had cardiovascular disease.
- Weight is one input among several, and your lab numbers show whether the change is reaching your arteries.
What weight loss changes in your numbers
Blood pressure. A pooled analysis of 25 randomized trials found that losing about 5 kg, roughly 11 pounds, lowered systolic blood pressure by about 4.4 mm Hg and diastolic pressure by about 3.6 mm Hg.1
Blood fats. A review of 73 randomized trials found that with diet and exercise programs, each kilogram lost went with triglycerides about 4 mg/dL lower, LDL cholesterol about 1.3 mg/dL lower and HDL cholesterol about 0.5 mg/dL higher after a year.2 Triglycerides respond the most and LDL the least.
Blood sugar. In the Diabetes Prevention Program, 3,234 adults with raised blood sugar were assigned to placebo, a diabetes medicine, or a lifestyle program that aimed for at least 7 percent weight loss and 150 minutes of activity a week. Over about three years, the lifestyle program cut new cases of type 2 diabetes by 58 percent compared with placebo.3 Our page on insulin resistance explains why that matters for your arteries.
The Look AHEAD result, stated plainly
Better risk factors should mean fewer heart attacks. Look AHEAD was the trial built to test that. It enrolled 5,145 adults with type 2 diabetes who were overweight or obese. Half received an intensive program of calorie reduction and physical activity. Half received standard diabetes support and education.
The program worked for weight. The intensive group lost 8.6 percent of body weight in the first year, compared with 0.7 percent in the comparison group. Blood sugar, fitness and most risk factors improved more in the intensive group. LDL cholesterol was the exception.
It did not work for the main goal. The trial was stopped early, at a median follow-up of 9.6 years, because the rate of heart attack, stroke, hospitalization for angina and cardiovascular death was nearly the same in both groups.4
What that result does and does not mean
It does not mean weight loss is pointless. It means this program, in this group, did not change hard outcomes over about a decade.
A few details help explain it. The weight gap shrank over time: by the end, the intensive group was down 6.0 percent and the comparison group 3.5 percent. LDL cholesterol, a main driver of plaque, did not differ between the groups.
A later look at the same data found that people who lost at least 10 percent of their body weight in the first year had a 21 percent lower risk of the main outcome than people whose weight stayed stable or rose.5 That finding is observational. People who manage to lose that much may differ in other ways, so it cannot prove cause.
Look AHEAD also studied only people with type 2 diabetes. It does not tell us what happens in people without diabetes.
What the newer medicine trials add
GLP-1 medicines are a class of prescription drugs that lower blood sugar and body weight. One of them was tested in the SELECT trial, which enrolled 17,604 adults aged 45 or older who had existing cardiovascular disease and a body mass index of 27 or higher, but no diabetes.
Over a mean follow-up of about 40 months, 6.5 percent of people taking the medicine had a heart attack, stroke or cardiovascular death, compared with 8.0 percent of people taking placebo.6 More people stopped the medicine because of side effects: 16.6 percent, compared with 8.2 percent on placebo.
This is real evidence, with limits. Everyone in the trial already had heart disease, so it does not show the same benefit for people who do not. The trial also could not separate how much of the benefit came from weight loss and how much from other effects of the drug. Our guide to GLP-1 medicines and heart risk goes through these trials in detail. Do not start, stop or change a medication without your prescriber.
Where the weight sits matters
The scale is a blunt tool. Fat stored deep in the abdomen, around the organs, is tied more closely to insulin resistance and heart risk than fat stored elsewhere. See our guide to visceral fat and heart risk for how this is assessed.
How to think about your own weight
Losing excess weight is worth doing for your blood pressure, blood sugar and triglycerides. It is not a substitute for knowing and managing your other risk factors.
The weak effect on LDL is the practical lesson. You can lose a meaningful amount of weight and still carry a high number of cholesterol particles. The reverse is also true: a person at a healthy weight can have high risk for inherited reasons.
Your next step: check what the scale cannot show
If weight is your main worry, two measurements fill in the picture. An ApoB test counts the particles that build plaque, which weight loss changes only a little. An A1c shows your average blood sugar over the past few months.
You can also answer the three quick questions in the Cardio Res-Q screener on our program page to see whether a closer evaluation makes sense for you.
Are You a Candidate for Cardio Res-Q?
Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.
Frequently asked questions
How much weight do I need to lose to help my heart?
There is no single threshold. In trials, blood pressure, triglycerides and blood sugar improved in step with the amount lost, and the Diabetes Prevention Program aimed for at least 7 percent of body weight. Whether a given amount lowers your chance of a heart attack has not been shown by a lifestyle trial, so the target is best set with your clinician.
Does Look AHEAD mean diet and exercise do not work?
No. The program improved weight, blood sugar, fitness and most risk factors. What it did not do was lower the rate of heart attacks and strokes in adults with type 2 diabetes over about ten years. That is a reason to manage cholesterol and blood pressure directly as well.
Will losing weight lower my LDL cholesterol?
Usually a little. In pooled trial data the drop was just over 1 mg/dL per kilogram lost with lifestyle programs. If your LDL or ApoB is high, weight loss alone often will not bring it to goal.
Should I ask about a weight-loss medicine for my heart?
That is a conversation for your prescriber. The strongest outcome evidence so far comes from people who already had cardiovascular disease, and the medicines have side effects that led some trial participants to stop.
Related reading
This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.
